Search results - 7 results
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
Cocuzza, Clementina E; Steven Van Gucht; Marc Van Ranst; M. Arbyn Source: Microbiol Spectr (2024) Keywords: Allplex COVID-19 diagnostics test accuracy Quality Control reference materials RT-PCR SARS-CoV-2 ...
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
of 107.5. These findings support the WHO 2021 recommendation that women living with HIV are screened with primary HPV testing in a screen-triage-and-treat approach starting at 25 years, with regular ...
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
testing on FVU (ratio, 0.94; 95% CI, 0.85-1.03), mC (ratio, 1.00; 95% CI, 0.94-1.06), and EB / QT (ratio, 0.92; 95% CI, 0.85-1.00) was not different to CCS s. Specificity on FVU was similar to CCS ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Organised Cervical Cancer Screening Programme (OCCSP) was started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test every 3 years in OCCSP. Despite implementation of the OCCSP, ...
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
biomarkers usable in managing screen-positive women. METHODS: We conducted a systematic review and meta-analysis assessing the accuracy of HPV- E6 / E7-oncoprotein tests to detect underlying cervical-precancer ...
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Abstract: The accuracy of high-risk human papillomavirus testing with the Xpert HPV assay on vaginal self-samples was compared ...
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Cervical Cancer Elimination Strategy recommend human papillomavirus (HPV) testing as the primary screening test. However, HPV testing is not widely available in the public healthcare system in Kenya. We ...